1 | Depatuxizumab | Depatuxizumab | 1471999-69-5 | 抗体抑制剂- | |
2 | Raxibacumab | 雷昔库单抗 | Raxibacumab | 565451-13-0 | 抗体抑制剂- | |
3 | Crizanlizumab | 立赞利珠单抗 | Crizanlizumab | 1690318-25-2 | 抗体抑制剂- | |
4 | 维汀-索非妥珠单抗 | Sofituzumab vedotin | 1418200-58-4 | 抗体抑制剂- | |
5 | Fazpilodemab | Fazpilodemab | 2517935-02-1 | 抗体抑制剂- | |
6 | Osemitamab | 奥塞米单抗 | Osemitamab | 2460539-61-9 | 抗体抑制剂- | |
7 | Visugromab | Visugromab | 2556646-63-8 | 抗体抑制剂- | |
8 | Vobramitamab | Vobramitamab | 2490556-50-6 | 抗体抑制剂- | |
9 | Posdinemab | Posdinemab | 2517973-04-3 | 抗体抑制剂- | |
10 | Semzuvolimab | Semzuvolimab | 2409099-32-5 | 抗体抑制剂- | |
11 | Reozalimab | Reozalimab | 2445259-99-2 | 抗体抑制剂- | |
12 | Zinlirvimab | Zinlirvimab | 2417213-75-1 | 抗体抑制剂- | |
13 | Bebtelovimab | 贝特洛韦单抗 | Bebtelovimab | 2578319-11-4 | 抗体抑制剂- | |
14 | Anselamimab | 安赛埃单抗 | Anselamimab | 2414866-63-8 | 抗体抑制剂- | |
15 | Trontinemab | Trontinemab | 2568868-35-7 | 抗体抑制剂- | |
16 | Linvoseltamab | 利伏赛坦单抗 | Linvoseltamab | 2408319-25-3 | 抗体抑制剂- | |
17 | Litifilimab | Litifilimab | 2407378-48-5 | 抗体抑制剂- | |
18 | Peresolimab | 佩瑞索利单抗 | Peresolimab | 2411580-63-5 | 抗体抑制剂- | |
19 | Rosnilimab | 罗斯尼利单抗 | Rosnilimab | 2412764-40-8 | 抗体抑制剂- | |
20 | Lifastuzumab | 利法妥珠单抗 | Lifastuzumab | 1615697-16-9 | 抗体抑制剂- | |
21 | Natalizumab (Solution) | Natalizumab (Solution) | 189261-10-7 | 抗体抑制剂- | |
22 | Ocrelizumab | 奥美珠单抗 | Ocrelizumab | 637334-45-3 | 抗体抑制剂- | |
23 | Trastuzumab (anti-HER2) | Trastuzumab (anti-HER2) | 180288-69-1 | 抗体抑制剂- | |
24 | Daratumumab | 达雷妥尤单抗 (PBS) | Daratumumab (PBS) | 945721-28-8 | 抗体抑制剂- | |
25 | Ramucirumab (anti-VEGFR) | Ramucirumab (anti-VEGFR) | 947687-13-0 | 抗体抑制剂- | |
26 | Necitumumab | 耐昔妥珠单抗 | Necitumumab | 906805-06-9 | 抗体抑制剂- | |
27 | Dinutuximab | 地努图希单抗 | Dinutuximab | 1363687-32-4 | 抗体抑制剂- | |
28 | Catumaxomab | 卡妥索单抗 | Catumaxomab | 509077-98-9 | 抗体抑制剂- | |
29 | Benralizumab (anti-IL5RA ) | Benralizumab (anti-IL5RA ) | 1044511-01-4 | 抗体抑制剂- | |
30 | Tulisokibart | Tulisokibart | 2648504-55-4 | 抗体抑制剂- | |
31 | Vantictumab | 万替妥单抗 | Vantictumab | 1345009-45-1 | 抗体抑制剂- | |
32 | Ozoralizumab | 奥利组单抗 | Ozoralizumab | 1167985-17-2 | 抗体抑制剂- | |
33 | Cofetuzumab | 考非妥珠单抗 | Cofetuzumab | 1869928-62-0 | 抗体抑制剂- | |
34 | Conbercept | 康柏西普单抗 | Conbercept | 1227158-72-6 | 抗体抑制剂- | |
35 | Duligotuzumab | 度戈妥珠单抗 | Duligotuzumab | 1314238-96-4 | 抗体抑制剂- | |
36 | Dusigitumab | 度司妥单抗 | Dusigitumab | 1204390-13-5 | 抗体抑制剂- | |
37 | Duvortuxizumab | 度妥昔珠单抗 | Duvortuxizumab | 1831098-91-9 | 抗体抑制剂- | |
38 | Eblasakimab | 伊沙奇单抗 | Eblasakimab | 2445460-16-0 | 抗体抑制剂- | |
39 | Ecromeximab | 依美昔单抗 | Ecromeximab | 292819-64-8 | 抗体抑制剂- | |
40 | Serclutamab | 思诺妥单抗 | Serclutamab | 2140172-41-2 | 抗体抑制剂- | |
41 | Samrotamab | 沙马妥单抗 | Samrotamab | 2052591-32-7 | 抗体抑制剂- | |
42 | Modotuximab | 扎妥昔单抗 | Modotuximab | 1310460-86-6 | 抗体抑制剂- | |
43 | Nisevokitug | Nisevokitug | 2649854-92-0 | 抗体抑制剂- | |
44 | Casdozokitug | Casdozokitug | 2643331-37-5 | 抗体抑制剂- | |
45 | Dargistotug | Dargistotug | 2649362-29-6 | 抗体抑制剂- | |
46 | Dalnicastobart | Dalnicastobart | 2642171-59-1 | 抗体抑制剂- | |
47 | Becotatug | Becotatug | 2648260-93-7 | 抗体抑制剂- | |
48 | Delpacibart | Delpacibart | 2653183-66-3 | 抗体抑制剂- | |
49 | Denosumab (anti-TNFSF11) | Denosumab (anti-TNFSF11) | 615258-40-7 | 抗体抑制剂- | |
50 | Isatuximab (anti-CD38) | Isatuximab (anti-CD38) | 1461640-62-9 | 抗体抑制剂- | |
51 | Enoticumab | 依诺苏单抗 | Enoticumab | 1192578-27-0 | 抗体抑制剂- | |
52 | Aflibercept (VEGF Trap) | Aflibercept (VEGF Trap) | 862111-32-8 | 抗体抑制剂- | |
53 | Boserolimab | Boserolimab | 2444297-08-7 | 抗体抑制剂- | |
54 | Exlinkibart | Exlinkibart | 2642171-64-8 | 抗体抑制剂- | |
55 | Evunzekibart | Evunzekibart | 2639688-77-8 | 抗体抑制剂- | |
56 | Fepixnebart | Fepixnebart | 2489584-93-0 | 抗体抑制剂- | |
57 | Bempikibart | Bempikibart | 2622254-57-1 | 抗体抑制剂- | |
58 | Ulviprubart | Ulviprubart | 2569434-60-0 | 抗体抑制剂- | |
59 | Etigilimab | 艾替利单抗 | Etigilimab | 2044984-83-8 | 抗体抑制剂- | |
60 | Empasiprubart | Empasiprubart | 2579031-19-7 | 抗体抑制剂- | |
61 | Izeltabart | Izeltabart | 2642078-60-0 | 抗体抑制剂- | |
62 | Perenostobart | Perenostobart | 2643331-31-9 | 抗体抑制剂- | |
63 | Anzurstobart | Anzurstobart | 2543693-10-1 | 抗体抑制剂- | |
64 | Belrestotug | 贝瑞苏塔单抗 | Belrestotug | 2574438-65-4 | 抗体抑制剂- | |
65 | Tobevibart | 托韦拜单抗 | Tobevibart | 2645440-65-7 | 抗体抑制剂- | |
66 | Pateclizumab | 帕替组单抗 | Pateclizumab | 1202526-59-7 | 抗体抑制剂- | |
67 | Raludotatug | Raludotatug | 2610074-56-9 | 抗体抑制剂- | |
68 | Linavonkibart | Linavonkibart | 2640981-30-0 | 抗体抑制剂- | |
69 | Polzastobart | Polzastobart | 2640981-19-5 | 抗体抑制剂- | |
70 | Zigakibart | 泽戈奇拜单抗 | Zigakibart | 2642175-46-8 | 抗体抑制剂- | |
71 | Quavonlimab | Quavonlimab | 2254059-25-9 | 抗体抑制剂- | |
72 | Volociximab | 伏洛昔单抗 | Volociximab | 558480-40-3 | 抗体抑制剂- | |
73 | Mepolizumab (anti-IL5) | Mepolizumab (anti-IL5) | 196078-29-2 | 抗体抑制剂- | |
74 | Avelumab (anti-PD-L1) | Avelumab (anti-PD-L1) | 1537032-82-8 | 抗体抑制剂- | |
75 | Enfortumab vedotin-ejfv (solution) | Enfortumab vedotin-ejfv (solution) | 1346452-25-2 | 抗体抑制剂- | |
76 | Varlilumab (anti-CD27) | Varlilumab (anti-CD27) | 1393344-72-3 | 抗体抑制剂- | |
77 | Abatacept (powder) | Abatacept (powder) | 332348-12-6 | 抗体抑制剂- | |
78 | Tezepelumab | 特泽鲁单抗 | Tezepelumab (anti-TSLP) | 1572943-04-4 | 抗体抑制剂- | |
79 | Cofetuzumab pelidotin | Cofetuzumab pelidotin | 1869937-48-3 | 抗体抑制剂- | |
80 | Durvalumab (anti-PD-L1) | Durvalumab (anti-PD-L1) | 1428935-60-7 | 抗体抑制剂- | |
81 | Lintuzumab | 林妥珠单抗 | Lintuzumab | 166089-32-3 | 抗体抑制剂- | |
82 | Elranatamab | 埃纳妥单抗 | Elranatamab | 2408850-14-4 | 抗体抑制剂- | |
83 | Suciraslimab | 舒西利单抗 | Suciraslimab | 2415439-63-1 | 抗体抑制剂- | |
84 | Trebananib | Trebananib | 894356-79-7 | 抗体抑制剂- | |
85 | Azintuxizumab vedotin | Azintuxizumab vedotin | 1826819-58-2 | 抗体抑制剂- | |
86 | Ladiratuzumab vedotin | Ladiratuzumab vedotin | 1629760-29-7 | 抗体抑制剂- | |
87 | Aprutumab ixadotin | Aprutumab ixadotin | 1708947-48-1 | 抗体抑制剂- | |
88 | Zolbetuximab | 佐妥昔单抗 | Zolbetuximab | 1496553-00-4 | 抗体抑制剂- | |
89 | Ipilimumab | 伊匹木单抗 | Ipilimumab | 477202-00-9 | 抗体抑制剂- | |
90 | Pembrolizumab | 帕博利珠单抗 | Pembrolizumab | 1374853-91-4 | 抗体抑制剂- | |
91 | Atezolizumab | 阿特珠单抗 | Atezolizumab | 1380723-44-3 | 抗体抑制剂- | |
92 | Cetuximab | 西妥昔单抗 | Cetuximab | 205923-56-4 | 抗体抑制剂- | |
93 | Bevacizumab | 贝伐珠单抗 | Bevacizumab | 216974-75-3 | 抗体抑制剂- | |
94 | Trastuzumab | 曲妥珠单抗 | Trastuzumab | 180288-69-1 | 抗体抑制剂- | |
95 | Adalimumab | 阿达木单抗 | Adalimumab | 331731-18-1 | 抗体抑制剂- | |
96 | Ustekinumab | 乌司奴单抗 | Ustekinumab | 815610-63-0 | 抗体抑制剂- | |
97 | Obinutuzumab | 奥滨尤妥珠单抗 | Obinutuzumab | 949142-50-1 | 抗体抑制剂- | |
98 | Rituximab | 利妥昔单抗 | Rituximab | 174722-31-7 | 抗体抑制剂- | |
99 | Vedolizumab | 维多珠单抗 | Vedolizumab | 943609-66-3 | 抗体抑制剂- | |
100 | Nivolumab | 纳武单抗 | Nivolumab | 946414-94-4 | 抗体抑制剂- | |
101 | Avelumab | 阿维鲁单抗 | Avelumab | 1537032-82-8 | 抗体抑制剂- | |
102 | Etanercept | 依那西普 | Etanercept | 185243-69-0 | 抗体抑制剂- | |
103 | Pertuzumab | 帕妥株单抗 | Pertuzumab | 380610-27-5 | 抗体抑制剂- | |
104 | Durvalumab | 德瓦鲁单抗 | Durvalumab | 1428935-60-7 | 抗体抑制剂- | |
105 | Tocilizumab | 托珠单抗 | Tocilizumab | 375823-41-9 | 抗体抑制剂- | |
106 | Belatacept | 贝拉西普 | Belatacept | 706808-37-9 | 抗体抑制剂- | |
107 | Brentuximab | Brentuximab | 2088770-90-3 | 抗体抑制剂- | |
108 | Abrilumab | 阿利鲁单抗 | Abrilumab | 1342290-43-0 | 抗体抑制剂- | |
109 | Anifrolumab | 阿鲁尼单抗 | Anifrolumab | 1326232-46-5 | 抗体抑制剂- | |
110 | Bapineuzumab | 巴匹珠单抗 | Bapineuzumab | 648895-38-9 | 抗体抑制剂- | |
111 | Blosozumab | 布索组单抗 | Blosozumab | 1132758-87-2 | 抗体抑制剂- | |
112 | Carlumab | 卡芦单抗 | Carlumab | 915404-94-3 | 抗体抑制剂- | |
113 | CC-90002 | CC-90002 | 2085844-54-6 | 抗体抑制剂- | |
114 | Cixutumumab | 西妥木单抗 | Cixutumumab | 947687-12-9 | 抗体抑制剂- | |
115 | CTX-471 | CTX-471 | 2377152-49-1 | 抗体抑制剂- | |
116 | Eldelumab | 埃迪鲁单抗 | Eldelumab | 946414-98-8 | 抗体抑制剂- | |
117 | Emibetuzumab | 依玛妥珠单抗 | Emibetuzumab | 1365287-97-3 | 抗体抑制剂- | |
118 | Evinacumab | 依维苏单抗 | Evinacumab | 1446419-85-7 | 抗体抑制剂- | |
119 | KWAR 23 | KWAR 23 | 2243227-60-1 | 抗体抑制剂- | |
120 | Mupadolimab | 莫帕利单抗 | Mupadolimab | 2451856-97-4 | 抗体抑制剂- | |
121 | Omburtamab | 奥博妥单抗 | Omburtamab | 1895083-75-6 | 抗体抑制剂- | |
122 | Uliledlimab | 尤莱利单抗 | Uliledlimab | 2378407-27-1 | 抗体抑制剂- | |
123 | Basiliximab | 巴利昔单抗 | Basiliximab | 179045-86-4 | 抗体抑制剂- | |
124 | Bexmarilimab | 贝马瑞利单抗 | Bexmarilimab | 2259301-27-2 | 抗体抑制剂- | |
125 | Caplacizumab | 卡拉西单抗 | Caplacizumab | 915810-67-2 | 抗体抑制剂- | |
126 | Daxdilimab | 达司迪利单抗 | Daxdilimab | 2245966-28-1 | 抗体抑制剂- | |
127 | Pivekimab | 匹维奇单抗 | Pivekimab | 2234335-84-1 | 抗体抑制剂- | |
128 | Rolinsatamab | 洛林妥单抗 | Rolinsatamab | 2095467-30-2 | 抗体抑制剂- | |
129 | Sofituzumab | 索非妥珠单抗 | Sofituzumab | 1615692-28-8 | 抗体抑制剂- | |
130 | Tabalumab | 他贝芦单抗 | Tabalumab | 1143503-67-6 | 抗体抑制剂- | |
131 | Tanezumab | 他尼组单抗 | Tanezumab | 880266-57-9 | 抗体抑制剂- | |
132 | Tovetumab | 托维妥单抗 | Tovetumab | 1243266-04-7 | 抗体抑制剂- | |
133 | Veltuzumab | 维妥组单抗 | Veltuzumab | 728917-18-8 | 抗体抑制剂- | |
134 | Muromonab | 莫罗单抗 | Muromonab | 140608-64-6 | 抗体抑制剂- | |
135 | Farletuzumab | 法妥组单抗 | Farletuzumab | 896723-44-7 | 抗体抑制剂- | |
136 | Zalutumumab | 扎芦木单抗 | Zalutumumab | 667901-13-5 | 抗体抑制剂- | |
137 | Relatlimab | 瑞拉利单抗 | Relatlimab | 1673516-98-7 | 抗体抑制剂- | |
138 | Labetuzumab | 拉贝珠单抗 | Labetuzumab | 219649-07-7 | 抗体抑制剂- | |
139 | Tilvestamab | 替卫妥单抗 | Tilvestamab | 2226775-26-2 | 抗体抑制剂- | |
140 | Nemolizumab | 奈莫利珠单抗 | Nemolizumab | 1476039-58-3 | 抗体抑制剂- | |
141 | Tilavonemab | 替拉奈单抗 | Tilavonemab | 2096513-89-0 | 抗体抑制剂- | |
142 | Zagotenemab | 泽格特奈单抗 | Zagotenemab | 2019133-28-7 | 抗体抑制剂- | |
143 | Upifitamab | 尤匹菲妥单抗 | Upifitamab | 2254118-43-7 | 抗体抑制剂- | |
144 | Edrecolomab | 依决洛单抗 | Edrecolomab | 156586-89-9 | 抗体抑制剂- | |
145 | Indusatumab | 英度妥单抗 | Indusatumab | 1497400-26-6 | 抗体抑制剂- | |
146 | Camidanlumab | 卡利尤单抗 | Camidanlumab | 921618-45-3 | 抗体抑制剂- | |
147 | Ponsegromab | Ponsegromab | 2368950-15-4 | 抗体抑制剂- | |
148 | Alsevalimab | 艾司沃利单抗 | Alsevalimab | 2254029-91-7 | 抗体抑制剂- | |
149 | Fezakinumab | 非扎奴单抗 | Fezakinumab | 1007106-86-6 | 抗体抑制剂- | |
150 | Emactuzumab | 依米妥珠单抗 | Emactuzumab | 1448221-67-7 | 抗体抑制剂- | |
151 | Vonlerolizumab | 珀伽利珠单抗 | Vonlerolizumab | 1638935-72-4 | 抗体抑制剂- | |
152 | Lodelcizumab | 洛迪赛珠单抗 | Lodelcizumab | 1355338-54-3 | 抗体抑制剂- | |
153 | Canakinumab | 卡那奴单抗 | Canakinumab | 914613-48-2 | 抗体抑制剂- | |
154 | Lucatumumab | 卢卡木单抗 | Lucatumumab | 903512-50-5 | 抗体抑制剂- | |
155 | Gevokizumab | 吉伏组单抗 | Gevokizumab | 1129435-60-4 | 抗体抑制剂- | |
156 | Enibarcimab | 恩巴瑞西单抗 | Enibarcimab | 2305638-98-4 | 抗体抑制剂- | |
157 | Abituzumab | 阿比妥珠单抗 | Abituzumab | 1105038-73-0 | 抗体抑制剂- | |
158 | Bococizumab | 伯考赛珠单抗 | Bococizumab | 1407495-02-6 | 抗体抑制剂- | |
159 | Emapalumab | 依马利尤单抗 | Emapalumab | 1709815-23-5 | 抗体抑制剂- | |
160 | Fasinumab | 法司努单抗 | Fasinumab | 1190239-42-9 | 抗体抑制剂- | |
161 | Cemiplimab | 西米普利单抗 | Cemiplimab | 1801342-60-8 | 抗体抑制剂- | |
162 | Glembatumumab | 格巴妥木单抗 | Glembatumumab | 1020264-78-1 | 抗体抑制剂- | |
163 | Naxitamab | 那昔妥单抗 | Naxitamab | 1879925-92-4 | 抗体抑制剂- | |
164 | Lenzilumab | 仑兹鲁单抗 | Lenzilumab | 1229575-09-0 | 抗体抑制剂- | |
165 | Olokizumab | 奥洛组单抗 | Olokizumab | 1007223-17-7 | 抗体抑制剂- | |
166 | Ozanezumab | 奥扎奈珠单抗 | Ozanezumab | 1310680-64-8 | 抗体抑制剂- | |
167 | Panobacumab | 帕巴库单抗 | Panobacumab | 885053-97-4 | 抗体抑制剂- | |
168 | Ponezumab | 泊奈组单抗 | Ponezumab | 1178862-65-1 | 抗体抑制剂- | |
169 | Rilotumumab | 利妥木单抗 | Rilotumumab | 872514-65-3 | 抗体抑制剂- | |
170 | Robatumumab | 罗妥木单抗 | Robatumumab | 934235-44-6 | 抗体抑制剂- | |
171 | Sifalimumab | 西法木单抗 | Sifalimumab | 1006877-41-3 | 抗体抑制剂- | |
172 | Teplizumab | 泰普利单抗 | Teplizumab | 876387-05-2 | 抗体抑制剂- | |
173 | Risankizumab | 瑞莎珠单抗 | Risankizumab | 1612838-76-2 | 抗体抑制剂- | |
174 | Ozuriftamab | Ozuriftamab | 2460399-44-2 | 抗体抑制剂- | |
175 | Foralumab | 福雷芦单抗 | Foralumab | 946415-64-1 | 抗体抑制剂- | |
176 | Mirvetuximab | 米妥昔单抗 | Mirvetuximab | 1453084-36-0 | 抗体抑制剂- | |
177 | Motavizumab | 莫维珠单抗 | Motavizumab | 677010-34-3 | 抗体抑制剂- | |
178 | Vibostolimab | 维博利单抗 | Vibostolimab | 2231305-30-7 | 抗体抑制剂- | |
179 | Lirilumab | 利瑞鲁单抗 | Lirilumab | 1000676-41-4 | 抗体抑制剂- | |
180 | Teprotumumab | 替妥木单抗 | Teprotumumab | 1036734-93-6 | 抗体抑制剂- | |
181 | Enokizumab | 依诺凯组单抗 | Enokizumab | 909875-08-7 | 抗体抑制剂- | |
182 | Ficlatuzumab | 非拉妥组单抗 | Ficlatuzumab | 1174900-84-5 | 抗体抑制剂- | |
183 | Bermekimab | 贝迈奇单抗 | Bermekimab | 1401965-15-8 | 抗体抑制剂- | |
184 | Etrolizumab | 依曲利组单抗 | Etrolizumab | 1044758-60-2 | 抗体抑制剂- | |
185 | Fletikumab | 夫来库单抗 | Fletikumab | 1357158-22-5 | 抗体抑制剂- | |
186 | Parsatuzumab | 帕萨妥珠单抗 | Parsatuzumab | 1312797-14-0 | 抗体抑制剂- | |
187 | Siltuximab | 司妥昔单抗 | Siltuximab | 541502-14-1 | 抗体抑制剂- | |
188 | Figitumumab | 芬妥木单抗 | Figitumumab | 943453-46-1 | 抗体抑制剂- | |
189 | Fulranumab | 福拉奴单抗 | Fulranumab | 902141-80-4 | 抗体抑制剂- | |
190 | Otelixizumab | 奥昔组单抗 | Otelixizumab | 881191-44-2 | 抗体抑制剂- | |
191 | Onartuzumab | 奥那妥组单抗 | Onartuzumab | 1133766-06-9 | 抗体抑制剂- | |
192 | Romosozumab | 罗莫单抗 | Romosozumab | 909395-70-6 | 抗体抑制剂- | |
193 | Efalizumab | 依法珠单抗 | Efalizumab | 214745-43-4 | 抗体抑制剂- | |
194 | Enoblituzumab | 依诺妥珠单抗 | Enoblituzumab | 1353485-38-7 | 抗体抑制剂- | |
195 | Serplulimab | 斯鲁利单抗 | Serplulimab | 2231029-82-4 | 抗体抑制剂- | |
196 | Ranibizumab (anti-VEGF) | Ranibizumab (anti-VEGF) | 347396-82-1 | 抗体抑制剂- | |
197 | Belantamab mafodotin | Belantamab mafodotin | 2050232-20-5 | 抗体抑制剂- | |
198 | Aflibercept | 阿柏西普单抗 | Aflibercept | 862111-32-8 | 抗体抑制剂- | |
199 | Efmoroctocog alfa | Efmoroctocog alfa | 1270012-79-7 | 抗体抑制剂- | |
200 | Inotuzumab | 奥英妥珠单抗 | Inotuzumab | 1660159-36-3 | 抗体抑制剂- | |
201 | Polatuzumab vedotin | Polatuzumab vedotin | 1313206-42-6 | 抗体抑制剂- | |
202 | Imalumab | 伊玛鲁单抗 | Imalumab | 1430205-07-4 | 抗体抑制剂- | |
203 | Mogamulizumab | 莫格利组单抗 | Mogamulizumab | 1159266-37-1 | 抗体抑制剂- | |
204 | Racotumomab | 雷妥莫单抗 | Racotumomab | 946832-34-4 | 抗体抑制剂- | |
205 | Inclacumab | Inclacumab | 1256258-86-2 | 抗体抑制剂- | |
206 | Itolizumab | 伊利组单抗 | Itolizumab | 1116433-11-4 | 抗体抑制剂- | |
207 | Quilizumab | 奎利珠单抗 | Quilizumab | 1228538-47-3 | 抗体抑制剂- | |
208 | Patritumab | 帕曲妥单抗 | Patritumab | 1262787-83-6 | 抗体抑制剂- | |
209 | Xentuzumab | 珍妥珠单抗 | Xentuzumab | 1417158-65-6 | 抗体抑制剂- | |
210 | Abagovomab | 阿巴伏单抗 | Abagovomab | 792921-10-9 | 抗体抑制剂- | |
211 | Ulocuplumab | 乌洛鲁单抗 | Ulocuplumab | 1375830-34-4 | 抗体抑制剂- | |
212 | Bavituximab | 巴维昔单抗 | Bavituximab | 648904-28-3 | 抗体抑制剂- | |
213 | Actoxumab | 阿克托舒单抗 | Actoxumab | 1245634-25-6 | 抗体抑制剂- | |
214 | Adecatumumab | 阿德木单抗 | Adecatumumab | 503605-66-1 | 抗体抑制剂- | |
215 | Vorsetuzumab | Vorsetuzumab | 1165740-62-4 | 抗体抑制剂- | |
216 | Perakizumab | 培拉凯珠单抗 | Perakizumab | 89957-37-9 | 抗体抑制剂- | |
217 | Tesidolumab | 特度鲁单抗 | Tesidolumab | 1531594-08-7 | 抗体抑制剂- | |
218 | Teneliximab | Teneliximab | 299423-37-3 | 抗体抑制剂- | |
219 | Ruplizumab | 卢利珠单抗 | Ruplizumab | 220651-94-5 | 抗体抑制剂- | |
220 | Solanezumab | 索拉珠单抗 | Solanezumab | 955085-14-0 | 抗体抑制剂- | |
221 | Sonepcizumab | Sonepcizumab | 1031360-18-5 | 抗体抑制剂- | |
222 | Timolumab | 替莫鲁单抗 | Timolumab | 1073538-99-4 | 抗体抑制剂- | |
223 | Tarextumab | 他瑞妥单抗 | Tarextumab | 1359940-55-8 | 抗体抑制剂- | |
224 | Talizumab | 他利珠单抗 | Talizumab | 380610-22-0 | 抗体抑制剂- | |
225 | Bimekizumab | 比美吉珠单抗 | Bimekizumab | 1418205-77-2 | 抗体抑制剂- | |
226 | Tositumomab | 托西莫单抗 | Tositumomab | 192391-48-3 | 抗体抑制剂- | |
227 | Sirukumab | 西鲁库单抗 | Sirukumab | 1194585-53-9 | 抗体抑制剂- | |
228 | Bivatuzumab | 比伐珠单抗 | Bivatuzumab | 214559-60-1 | 抗体抑制剂- | |
229 | Drozitumab | 曲齐妥单抗 | Drozitumab | 912628-39-8 | 抗体抑制剂- | |
230 | Epratuzumab | Epratuzumab | 205923-57-5 | 抗体抑制剂- | |
231 | Fontolizumab | 芳妥珠单抗 | Fontolizumab | 326859-36-3 | 抗体抑制剂- | |
232 | Galiximab | 加利昔单抗 | Galiximab | 357613-77-5 | 抗体抑制剂- | |
233 | Ligelizumab | 利戈组单抗 | Ligelizumab | 1322627-61-1 | 抗体抑制剂- | |
234 | Tildrakizumab | 替曲吉珠单抗 | Tildrakizumab | 1326244-10-3 | 抗体抑制剂- | |
235 | Ganitumab | 加尼妥单抗 | Ganitumab | 905703-97-1 | 抗体抑制剂- | |
236 | Etaracizumab | 埃达组单抗 | Etaracizumab | 892553-42-3 | 抗体抑制剂- | |
237 | Intetumumab | 英妥木单抗 | Intetumumab | 725735-28-4 | 抗体抑制剂- | |
238 | Imgatuzumab | 伊马曲单抗 | Imgatuzumab | 959963-46-3 | 抗体抑制剂- | |
239 | Bleselumab | Bleselumab | 1453067-91-8 | 抗体抑制剂- | |
240 | Brontictuzumab | 布隆妥珠单抗 | Brontictuzumab | 1447814-75-6 | 抗体抑制剂- | |
241 | Prezalumab | 普瑞鲁单抗 | Prezalumab | 1523164-68-2 | 抗体抑制剂- | |
242 | Cabiralizumab | 卡比利珠单抗 | Cabiralizumab | 1613144-80-1 | 抗体抑制剂- | |
243 | Lokivetmab | 洛吉维单抗 | Lokivetmab | 1533403-95-0 | 抗体抑制剂- | |
244 | Lulizumab | 鲁利珠单抗 | Lulizumab | 2235419-62-0 | 抗体抑制剂- | |
245 | Lumiliximab | 鲁昔单抗 | Lumiliximab | 357613-86-6 | 抗体抑制剂- | |
246 | Lumretuzumab | 鲁妥珠单抗 | Lumretuzumab | 1448327-63-6 | 抗体抑制剂- | |
247 | Ocaratuzumab | 奥卡妥珠单抗 | Ocaratuzumab | 1169956-08-4 | 抗体抑制剂- | |
248 | Pagibaximab | 帕昔单抗 | Pagibaximab | 595566-61-3 | 抗体抑制剂- | |
249 | Namilumab | 那美芦单抗 | Namilumab | 1206681-39-1 | 抗体抑制剂- | |
250 | Rontalizumab | 隆利组单抗 | Rontalizumab | 948570-30-7 | 抗体抑制剂- | |
251 | Zanolimumab | 扎木单抗 | Zanolimumab | 652153-01-0 | 抗体抑制剂- | |
252 | Conatumumab | Conatumumab | 896731-82-1 | 抗体抑制剂- | |
253 | Demcizumab | Demcizumab | 1243262-17-0 | 抗体抑制剂- | |
254 | Seribantumab | 瑟瑞妥单抗 | Seribantumab | 1334296-12-6 | 抗体抑制剂- | |
255 | Sibrotuzumab | 西罗珠单抗 | Sibrotuzumab | 216669-97-5 | 抗体抑制剂- | |
256 | Tisotumab | 替索妥单抗 | Tisotumab | 1418628-81-5 | 抗体抑制剂- | |
257 | Lexatumumab | 来沙木单抗 | Lexatumumab | 845816-02-6 | 抗体抑制剂- | |
258 | Lampalizumab | 兰帕利珠单抗 | Lampalizumab | 1278466-20-8 | 抗体抑制剂- | |
259 | Elsilimomab | Elsilimomab | 468715-71-1 | 抗体抑制剂- | |
260 | Tigatuzumab | 替加组单抗 | Tigatuzumab | 918127-53-4 | 抗体抑制剂- | |
261 | Bedinvetmab | 贝汀维单抗 | Bedinvetmab | 2171034-69-6 | 抗体抑制剂- | |
262 | FG-3019 | FG-3019 | 946415-13-0 | 抗体抑制剂- | |
263 | Ansuvimab | 安舒韦单抗 | Ansuvimab | 2375952-29-5 | 抗体抑制剂- | |
264 | Tebentafusp | Tebentafusp | 1874157-95-5 | 抗体抑制剂- | |
265 | Sotrovimab | 索托韦单抗 | Sotrovimab | 2423014-07-5 | 抗体抑制剂- | |
266 | Casirivimab | 卡西瑞单抗 | Casirivimab | 2415933-42-3 | 抗体抑制剂- | |
267 | Imdevimab | 伊德单抗 | Imdevimab | 2415933-40-1 | 抗体抑制剂- | |
268 | Atoltivimab | 阿替韦单抗 | Atoltivimab | 2135632-29-8 | 抗体抑制剂- | |
269 | Bamlanivimab | 巴尼韦单抗 | Bamlanivimab | 2423943-37-5 | 抗体抑制剂- | |
270 | Tagitanlimab | 泰特利单抗 | Tagitanlimab | 2417649-97-7 | 抗体抑制剂- | |
271 | Suvratoxumab | 苏托舒单抗 | Suvratoxumab | 1629620-18-3 | 抗体抑制剂- | |
272 | Clenoliximab | 克立昔单抗 | Clenoliximab | 182912-58-9 | 抗体抑制剂- | |
273 | Toralizumab | 托拉珠单抗 | Toralizumab | 252662-47-8 | 抗体抑制剂- | |
274 | Dostarlimab | 多塔利单抗 | Dostarlimab | 2022215-59-2 | 抗体抑制剂- | |
275 | Loncastuximab tesirine | Loncastuximab tesirine | 1879918-31-6 | 抗体抑制剂- | |
276 | Gresonitamab | Gresonitamab | 2413817-97-5 | 抗体抑制剂- | |
277 | Andecaliximab | 安德利昔单抗 | Andecaliximab | 1518996-49-0 | 抗体抑制剂- | |
278 | Anetumab | 阿奈妥单抗 | Anetumab | 1954758-84-9 | 抗体抑制剂- | |
279 | Ascrinvacumab | 阿伐苏单抗 | Ascrinvacumab | 1463459-96-2 | 抗体抑制剂- | |
280 | Bimagrumab | 比玛卢单抗 | Bimagrumab | 1356922-05-8 | 抗体抑制剂- | |
281 | Cantuzumab mertansine | 莫坎妥珠单抗 | Cantuzumab mertansine | 400010-39-1 | 抗体抑制剂- | |
282 | Cendakimab | 申达奇单抗 | Cendakimab | 2151032-62-9 | 抗体抑制剂- | |
283 | Tebotelimab | 特泊利单抗 | Tebotelimab | 2245725-04-4 | 抗体抑制剂- | |
284 | Tarlatamab | 塔拉妥单抗 | Tarlatamab | 2307488-83-9 | 抗体抑制剂- | |
285 | Cifurtilimab | Cifurtilimab | 1629760-27-5 | 抗体抑制剂- | |
286 | Cirevetmab | Cirevetmab | 2473240-98-9 | 抗体抑制剂- | |
287 | Concizumab | 康赛珠单抗 | Concizumab | 1312299-39-0 | 抗体抑制剂- | |
288 | Neihulizumab | Neihulizumab | 2158362-38-8 | 抗体抑制剂- | |
289 | Lorvotuzumab | 洛沃妥珠单抗 | Lorvotuzumab | 339306-30-8 | 抗体抑制剂- | |
290 | Naratuximab | 那妥昔单抗 | Naratuximab | 1622327-39-2 | 抗体抑制剂- | |
291 | Elezanumab | 依来努单抗 | Elezanumab | 1791416-49-3 | 抗体抑制剂- | |
292 | Ensituximab | 恩妥昔单抗 | Ensituximab | 1092658-06-4 | 抗体抑制剂- | |
293 | Samalizumab | 沙马组单抗 | Samalizumab | 1073059-33-2 | 抗体抑制剂- | |
294 | Prasinezumab | 普尼珠单抗 | Prasinezumab | 1960462-19-4 | 抗体抑制剂- | |
295 | Landogrozumab | 兰洛珠单抗 | Landogrozumab | 1391726-30-9 | 抗体抑制剂- | |
296 | Lirentelimab | 莱瑞利单抗 | Lirentelimab | 2283348-97-8 | 抗体抑制剂- | |
297 | Icrucumab | 艾芦库单抗 | Icrucumab | 1024603-92-6 | 抗体抑制剂- | |
298 | Oxelumab | 奥塞芦单抗 | Oxelumab | 1186098-83-8 | 抗体抑制剂- | |
299 | Dalotuzumab | 达罗托组单抗 | Dalotuzumab | 1005389-60-5 | 抗体抑制剂- | |
300 | Feladilimab | Feladilimab | 2252518-85-5 | 抗体抑制剂- | |
301 | Visilizumab | 维西珠单抗 | Visilizumab | 219716-33-3 | 抗体抑制剂- | |
302 | Vanucizumab | 伐努赛珠单抗 | Vanucizumab | 1448221-05-3 | 抗体抑制剂- | |
303 | Vadastuximab | 伐达妥昔单抗 | Vadastuximab | 1436390-64-5 | 抗体抑制剂- | |
304 | Enlimomab | 恩莫单抗 | Enlimomab | 142864-19-5 | 抗体抑制剂- | |
305 | Enapotamab | Enapotamab | 1912423-61-0 | 抗体抑制剂- | |
306 | Tucotuzumab | 西莫白介素单抗 | Tucotuzumab | 339986-90-2 | 抗体抑制剂- | |
307 | Tregalizumab | 曲利组单抗 | Tregalizumab | 1207446-68-1 | 抗体抑制剂- | |
308 | Ifinatamab | Ifinatamab | 2484870-90-6 | 抗体抑制剂- | |
309 | Nidanilimab | 尼达利单抗 | Nidanilimab (Nadunolimab) | 2171061-85-9 | 抗体抑制剂- | |
310 | Lacutamab | 拉可妥单抗 | Lacutamab | 2187368-16-5 | 抗体抑制剂- | |
311 | Navicixizumab | 那赛昔珠单抗 | Navicixizumab | 1638338-43-8 | 抗体抑制剂- | |
312 | Vofatamab | 沃凡妥单抗 | Vofatamab | 1312305-12-6 | 抗体抑制剂- | |
313 | Vobarilizumab | 沃巴利珠单抗 | Vobarilizumab | 1628814-88-9 | 抗体抑制剂- | |
314 | Tesnatilimab | Tesnatilimab | 2242758-08-1 | 抗体抑制剂- | |
315 | Trevogrumab | 曲戈卢单抗 | Trevogrumab | 1429201-24-0 | 抗体抑制剂- | |
316 | Tepoditamab | Tepoditamab | 2044679-53-8 | 抗体抑制剂- | |
317 | Cinpanemab | 辛帕奈单抗 | Cinpanemab | 2094516-02-4 | 抗体抑制剂- | |
318 | Enavatuzumab | 依那妥组单抗 | Enavatuzumab | 1062149-33-0 | 抗体抑制剂- | |
319 | Bavunalimab | Bavunalimab | 2329669-78-3 | 抗体抑制剂- | |
320 | Crotedumab | 克罗特度单抗 | Crotedumab | 1452387-69-7 | 抗体抑制剂- | |
321 | Dezamizumab | 迪扎米珠单抗 | Dezamizumab | 1662664-56-3 | 抗体抑制剂- | |
322 | Telisotuzumab | 特立妥珠单抗 | Telisotuzumab | 1781223-80-0 | 抗体抑制剂- | |
323 | Teclistamab | 特立妥单抗 | Teclistamab | 2119595-80-9 | 抗体抑制剂- | |
324 | Tavolixizumab | Tavolixizumab | 1635395-25-3 | 抗体抑制剂- | |
325 | Rinucumab | 利努苏单抗 | Rinucumab | 1569263-06-4 | 抗体抑制剂- | |
326 | Refanezumab | 瑞法奈珠单抗 | Refanezumab | 1233953-61-1 | 抗体抑制剂- | |
327 | Etesevimab | 埃特司韦单抗 | Etesevimab | 2423948-94-9 | 抗体抑制剂- | |
328 | Regdanvimab | 瑞丹维单抗 | Regdanvimab | 2444308-95-4 | 抗体抑制剂- | |
329 | Ravulizumab | 雷夫利珠单抗 | Ravulizumab | 1803171-55-2 | 抗体抑制剂- | |
330 | Ogalvibart | Ogalvibart | 2599039-60-6 | 抗体抑制剂- | |
331 | Denintuzumab | 地宁妥珠单抗 | Denintuzumab | 1630074-14-4 | 抗体抑制剂- | |
332 | Setrusumab | Setrusumab | 1847394-95-9 | 抗体抑制剂- | |
333 | Semorinemab | 西瑞奈单抗 | Semorinemab | 2159141-27-0 | 抗体抑制剂- | |
334 | Cilgavimab | 西加韦单抗 | Cilgavimab | 2420563-99-9 | 抗体抑制剂- | |
335 | Rosmantuzumab | 洛曼妥珠单抗 | Rosmantuzumab | 1684393-04-1 | 抗体抑制剂- | |
336 | Volagidemab | 沃拉德单抗 | Volagidemab | 1233956-13-2 | 抗体抑制剂- | |
337 | Vesencumab | 维森库单抗 | Vesencumab | 1205533-60-3 | 抗体抑制剂- | |
338 | IMAB027 | IMAB027 | 1650599-68-0 | 抗体抑制剂- | |
339 | Talquetamab | 塔奎妥单抗 | Talquetamab | 2226212-40-2 | 抗体抑制剂- | |
340 | Spesolimab | 佩索利单抗 | Spesolimab | 2097104-58-8 | 抗体抑制剂- | |
341 | Zenocutuzumab | 泽妥珠单抗 | Zenocutuzumab | 1969309-56-5 | 抗体抑制剂- | |
342 | Zelminemab | 泽米奈单抗 | Zelminemab | 2225850-33-7 | 抗体抑制剂- | |
343 | Abrezekimab | 阿泽奇单抗 | Abrezekimab | 2043952-59-4 | 抗体抑制剂- | |
344 | Adebrelimab | 阿得贝利单抗 | Adebrelimab | 2247114-85-6 | 抗体抑制剂- | |
345 | Afasevikumab | 阿法库单抗 | Afasevikumab | 1589503-30-9 | 抗体抑制剂- | |
346 | Zalifrelimab | 泽弗利单抗 | Zalifrelimab | 2148321-69-9 | 抗体抑制剂- | |
347 | Narsoplimab | 纳索利单抗 | Narsoplimab | 2108782-45-0 | 抗体抑制剂- | |
348 | Vopratelimab | 伏派利单抗 | Vopratelimab | 2039148-04-2 | 抗体抑制剂- | |
349 | Lusvertikimab | 芦维奇单抗 | Lusvertikimab | 2375835-91-7 | 抗体抑制剂- | |
350 | Talacotuzumab | 塔妥珠单抗 | Talacotuzumab | 1826831-79-1 | 抗体抑制剂- | |
351 | Sonelokimab | 索洛奇单抗 | Sonelokimab | 1414386-05-2 | 抗体抑制剂- | |
352 | Paridiprubart | Paridiprubart | 2641646-59-3 | 抗体抑制剂- | |
353 | Lacnotuzumab | Lacnotuzumab | 1831128-32-5 | 抗体抑制剂- | |
354 | Pepinemab | 派比奈单抗 | Pepinemab | 2097151-87-4 | 抗体抑制剂- | |
355 | Ontamalimab | 昂塔利单抗 | Ontamalimab | 2098790-40-8 | 抗体抑制剂- | |
356 | Vibecotamab | 维克妥单抗 | Vibecotamab | 2138442-13-2 | 抗体抑制剂- | |
357 | Vatelizumab | 伐利组单抗 | Vatelizumab | 1238217-55-4 | 抗体抑制剂- | |
358 | Varisacumab | 伐利苏单抗 | Varisacumab | 1610010-60-0 | 抗体抑制剂- | |
359 | Ublituximab | 乌妥昔单抗 | Ublituximab | 1174014-05-1 | 抗体抑制剂- | |
360 | Tuvonralimab | 托沃瑞利单抗 | Tuvonralimab | 2417649-44-4 | 抗体抑制剂- | |
361 | Tulinercept | Tulinercept | 1623177-41-2 | 抗体抑制剂- | |
362 | Trinbelimab | 曲柏利单抗 | Trinbelimab | 2415078-44-1 | 抗体抑制剂- | |
363 | Tosatoxumab | 托萨托舒单抗 | Tosatoxumab | 1374419-41-6 | 抗体抑制剂- | |
364 | Burosumab | 布洛舒单抗 | Burosumab | 1610833-03-8 | 抗体抑制剂- | |
365 | Abelacimab | 阿贝西单抗 | Abelacimab | 2098724-83-3 | 抗体抑制剂- | |
366 | Anbenitamab | Anbenitamab | 2367012-88-0 | 抗体抑制剂- | |
367 | Anivovetmab | Anivovetmab | 2370896-63-0 | 抗体抑制剂- | |
368 | Astegolimab | 艾特利单抗 | Astegolimab | 2173054-79-8 | 抗体抑制剂- | |
369 | Ziltivekimab | 泽韦奇单抗 | Ziltivekimab | 2226654-05-1 | 抗体抑制剂- | |
370 | Mirikizumab | 米吉珠单抗 | Mirikizumab | 1884201-71-1 | 抗体抑制剂- | |
371 | Amivantamab | 埃万妥单抗 | Amivantamab | 2171511-58-1 | 抗体抑制剂- | |
372 | Quisovalimab | 奎索利单抗 | Quisovalimab | 2427667-03-4 | 抗体抑制剂- | |
373 | Atacicept | 阿塞西普 | Atacicept | 845264-92-8 | 抗体抑制剂- | |
374 | Tozorakimab | 托雷奇单抗 | Tozorakimab | 2376858-66-9 | 抗体抑制剂- | |
375 | Telitacicept | 泰它西普 | Telitacicept | 2136630-26-5 | 抗体抑制剂- | |
376 | Tidutamab | 泰妥单抗 | Tidutamab | 2148354-90-7 | 抗体抑制剂- | |
377 | Urtoxazumab | 乌珠单抗 | Urtoxazumab | 502496-16-4 | 抗体抑制剂- | |
378 | Urabrelimab | Urabrelimab | 2249722-58-3 | 抗体抑制剂- | |
379 | Vapaliximab | 伐利昔单抗 | Vapaliximab | 336801-86-6 | 抗体抑制剂- | |
380 | Tixagevimab | 替沙格韦单抗 | Tixagevimab | 2420564-02-7 | 抗体抑制剂- | |
381 | Atidortoxumab | 阿度尤单抗 | Atidortoxumab | 1939108-95-8 | 抗体抑制剂- | |
382 | Avizakimab | 艾维奇单抗 | Avizakimab | 2229685-51-0 | 抗体抑制剂- | |
383 | Bafisontamab | 巴弗妥单抗 | Bafisontamab | 2437210-79-0 | 抗体抑制剂- | |
384 | Tibulizumab | 替布利珠单抗 | Tibulizumab | 1849636-24-3 | 抗体抑制剂- | |
385 | Bapotulimab | 巴泊妥利单抗 | Bapotulimab | 2359413-58-2 | 抗体抑制剂- | |
386 | Trastuzumab duocarmazine | Trastuzumab duocarmazine | 1642152-40-6 | 抗体抑制剂- | |
387 | Detumomab | 地莫单抗 | Detumomab | 145832-33-3 | 抗体抑制剂- | |
388 | Timigutuzumab | 替米妥珠单抗 | Timigutuzumab | 1665274-14-5 | 抗体抑制剂- | |
389 | Barecetamab | Barecetamab | 2275727-74-5 | 抗体抑制剂- | |
390 | Birtamimab | 泊特埃单抗 | Birtamimab | 1608108-91-3 | 抗体抑制剂- | |
391 | Barzolvolimab | 巴佐利单抗 | Barzolvolimab | 2438203-51-9 | 抗体抑制剂- | |
392 | Begelomab | 贝戈洛单抗 | Begelomab | 1403744-56-8 | 抗体抑制剂- | |
393 | Disitamab | 迪西妥单抗 | Disitamab | 2185868-98-6 | 抗体抑制剂- | |
394 | Divozilimab | Divozilimab | 2254061-60-2 | 抗体抑制剂- | |
395 | Donanemab | 多奈单抗 | Donanemab | 1931944-80-7 | 抗体抑制剂- | |
396 | Brodalumab | 布罗利尤单抗 | Brodalumab | 1174395-19-7 | 抗体抑制剂- | |
397 | Bifikafusp alfa | Bifikafusp alfa | 1957239-90-5 | 抗体抑制剂- | |
398 | Aselizumab | 阿塞珠单抗 | Aselizumab | 395639-53-9 | 抗体抑制剂- | |
399 | Bectumomab | 贝妥莫单抗 | Bectumomab | 158318-63-9 | 抗体抑制剂- | |
400 | Tenatumomab | 替妥莫单抗 | Tenatumomab | 1412891-40-7 | 抗体抑制剂- | |
401 | Afelimomab | 阿非莫单抗 | Afelimomab | 156227-98-4 | 抗体抑制剂- | |
402 | Albinterferon alfa-2B | Albinterferon alfa-2B | 472960-22-8 | 抗体抑制剂- | |
403 | Bepranemab | 贝瑞奈单抗 | Bepranemab | 2244960-75-4 | 抗体抑制剂- | |
404 | Bersanlimab | Bersanlimab | 1987854-08-9 | 抗体抑制剂- | |
405 | Bertilimumab | 柏替木单抗 | Bertilimumab | 375348-49-5 | 抗体抑制剂- | |
406 | Betifisolimab | Betifisolimab | 2460539-60-8 | 抗体抑制剂- | |
407 | Anrukinzumab | 安芦组单抗 | Anrukinzumab | 910649-32-0 | 抗体抑制剂- | |
408 | Asunercept | Asunercept | 1450882-18-4 | 抗体抑制剂- | |
409 | Avdoralimab | 艾朵利单抗 | Avdoralimab | 2226393-85-5 | 抗体抑制剂- | |
410 | Clesrovimab | Clesrovimab | 2429913-18-6 | 抗体抑制剂- | |
411 | Pascolizumab | 帕考珠单抗 | Pascolizumab | 331243-22-2 | 抗体抑制剂- | |
412 | Porgaviximab | 珀韦昔单抗 | Porgaviximab | 1792982-55-8 | 抗体抑制剂- | |
413 | Tafolecimab | 托莱西单抗 | Tafolecimab | 2225109-03-3 | 抗体抑制剂- | |
414 | Vunakizumab | Vunakizumab | 1792181-33-9 | 抗体抑制剂- | |
415 | Tabituximab | 坦比妥昔单抗 | Tabituximab | 1644134-10-0 | 抗体抑制剂- | |
416 | Burfiralimab | Burfiralimab | 2460809-80-5 | 抗体抑制剂- | |
417 | Tamgiblimab | Tamgiblimab | 2411914-36-6 | 抗体抑制剂- | |
418 | Camoteskimab | Camoteskimab | 2492472-82-7 | 抗体抑制剂- | |
419 | Cantuzumab ravtansine | Cantuzumab ravtansine | 868747-45-9 | 抗体抑制剂- | |
420 | Carotuximab | 卡妥昔单抗 | Carotuximab | 1268714-50-6 | 抗体抑制剂- | |
421 | Tadocizumab | 他度组单抗 | Tadocizumab | 339086-80-5 | 抗体抑制剂- | |
422 | Tabituximab barzuxetan (exclude Y90) | Tabituximab barzuxetan (exclude Y90) | 1612758-88-9 | 抗体抑制剂- | |
423 | Telazorlimab | 特拉佐利单抗 | Telazorlimab | 2126777-87-3 | 抗体抑制剂- | |
424 | Tefibazumab | 替非组单抗 | Tefibazumab | 521079-87-8 | 抗体抑制剂- | |
425 | Tomaralimab | 托拉利单抗 | Tomaralimab | 1449294-76-1 | 抗体抑制剂- | |
426 | Azintuxizumab | 阿妥昔珠单抗 | Azintuxizumab | 1826819-57-1 | 抗体抑制剂- | |
427 | Prolgolimab | 帕洛利单抗 | Prolgolimab | 2093956-19-3 | 抗体抑制剂- | |
428 | Garivulimab | Garivulimab | 2342597-81-1 | 抗体抑制剂- | |
429 | Garetosmab | 加托索单抗 | Garetosmab | 2097125-54-5 | 抗体抑制剂- | |
430 | Garadacimab | 加达西单抗 | Garadacimab | 2162134-62-3 | 抗体抑制剂- | |
431 | Gancotamab | 甘妥单抗 | Gancotamab | 1509928-00-0 | 抗体抑制剂- | |
432 | Galegenimab | 戈莱恩尼单抗 | Galegenimab | 2403683-24-7 | 抗体抑制剂- | |
433 | Futuximab | 伏妥昔单抗 | Futuximab | 1310460-85-5 | 抗体抑制剂- | |
434 | Frunevetmab | 夫卢维单抗 | Frunevetmab | 1708936-80-4 | 抗体抑制剂- | |
435 | Frovocimab | 弗洛西单抗 | Frovocimab | 1643672-70-1 | 抗体抑制剂- | |
436 | Frexalimab | Frexalimab | 2515463-86-0 | 抗体抑制剂- | |
437 | Foravirumab | 福拉韦单抗 | Foravirumab | 944548-38-3 | 抗体抑制剂- | |
438 | Flanvotumab | 法兰妥单抗 | Flanvotumab | 1188277-05-5 | 抗体抑制剂- | |
439 | Fiztasovimab | Fiztasovimab | 2467411-25-0 | 抗体抑制剂- | |
440 | Firivumab | 非利伏单抗 | Firivumab | 1443004-15-6 | 抗体抑制剂- | |
441 | Fidasimtamab | Fidasimtamab | 2377419-89-9 | 抗体抑制剂- | |
442 | Fianlimab | 弗安利单抗 | Fianlimab | 2126132-98-5 | 抗体抑制剂- | |
443 | Felzartamab | 菲泽妥单抗 | Felzartamab | 2197112-39-1 | 抗体抑制剂- | |
444 | Faralimomab | 法拉莫单抗 | Faralimomab | 167816-91-3 | 抗体抑制剂- | |
445 | Ezabenlimab | 埃本利单抗 | Ezabenlimab | 2249882-54-8 | 抗体抑制剂- | |
446 | Exbivirumab | 艾韦单抗 | Exbivirumab | 569658-80-6 | 抗体抑制剂- | |
447 | Tamtuvetmab | 坦妥维单抗 | Tamtuvetmab | 1608122-71-9 | 抗体抑制剂- | |
448 | Tirnovetmab | 替尔维单抗 | Tirnovetmab | 2364504-80-1 | 抗体抑制剂- | |
449 | Tamrintamab | 他林妥单抗 | Tamrintamab | 2148325-59-9 | 抗体抑制剂- | |
450 | Cetrelimab | 西利单抗 | Cetrelimab | 2050478-92-5 | 抗体抑制剂- | |
451 | 阿姆白介素-2-瑟妥珠单抗 | Cergutuzumab amunaleukin | 1509916-03-3 | 抗体抑制剂- | |
452 | Budigalimab | 布格利单抗 | Budigalimab | 2098225-93-3 | 抗体抑制剂- | |
453 | Briquilimab | Briquilimab | 2574591-89-0 | 抗体抑制剂- | |
454 | Briobacept | Briobacept | 869881-54-9 | 抗体抑制剂- | |
455 | Briakinumab | 布雷奴单抗 | Briakinumab | 339308-60-0 | 抗体抑制剂- | |
456 | Brazikumab | 布雷库单抗 | Brazikumab | 1610353-18-8 | 抗体抑制剂- | |
457 | Blontuvetmab | 布隆妥维单抗 | Blontuvetmab | 1608112-78-2 | 抗体抑制剂- | |
458 | Berlimatoxumab | 贝度尤单抗 | Berlimatoxumab | 1939109-24-6 | 抗体抑制剂- | |
459 | Baminercept | Baminercept | 909110-25-4 | 抗体抑制剂- | |
460 | Atinumab | 阿替奴单抗 | Atinumab | 1226761-65-4 | 抗体抑制剂- | |
461 | Apolizumab | 阿泊珠单抗 | Apolizumab | 267227-08-7 | 抗体抑制剂- | |
462 | Apitegromab | 阿匹特古单抗 | Apitegromab | 2278276-46-1 | 抗体抑制剂- | |
463 | Alefacept | Alefacept | 222535-22-0 | 抗体抑制剂- | |
464 | Quetmolimab | 奎莫利单抗 | Quetmolimab | 2084037-83-0 | 抗体抑制剂- | |
465 | Tomuzotuximab | 托木妥昔单抗 | Tomuzotuximab | 1646321-00-7 | 抗体抑制剂- | |
466 | Gatipotuzumab | 伽妥珠单抗 | Gatipotuzumab | 1264737-26-9 | 抗体抑制剂- | |
467 | Flotetuzumab | 伏妥珠单抗 | Flotetuzumab | 1664355-28-5 | 抗体抑制剂- | |
468 | Sibeprenlimab | 西贝瑞单抗 | Sibeprenlimab | 2382896-07-1 | 抗体抑制剂- | |
469 | Rilonacept | 利纳西普 | Rilonacept | 501081-76-1 | 抗体抑制剂- | |
470 | Batiraxcept | Batiraxcept | 2268717-61-7 | 抗体抑制剂- | |
471 | Tarcocimab | 塔珂西单抗 | Tarcocimab | 2408661-40-3 | 抗体抑制剂- | |
472 | Gedivumab | 格迪伏单抗 | Gedivumab | 1807954-17-1 | 抗体抑制剂- | |
473 | Gefurulimab | Gefurulimab | 2456407-94-4 | 抗体抑制剂- | |
474 | Efruxifermin | Efruxifermin | 2375240-92-7 | 抗体抑制剂- | |
475 | Efineptakin alfa | Efineptakin alfa | 2026634-47-7 | 抗体抑制剂- | |
476 | Remtolumab | 壬托鲁单抗 | Remtolumab | 1791410-27-9 | 抗体抑制剂- | |
477 | Rocatinlimab | 诺卡替利单抗 | Rocatinlimab | 2431972-52-8 | 抗体抑制剂- | |
478 | Retifanlimab | 瑞弗利单抗 | Retifanlimab | 2079108-44-2 | 抗体抑制剂- | |
479 | Geptanolimab | 杰洛利单抗 | Geptanolimab | 2348469-43-0 | 抗体抑制剂- | |
480 | Giloralimab | Giloralimab | 2226292-20-0 | 抗体抑制剂- | |
481 | Gilvetmab | 吉维单抗 | Gilvetmab | 1808081-43-7 | 抗体抑制剂- | |
482 | Glenzocimab | 格仑西单抗 | ACT017 | 2101829-58-5 | 抗体抑制剂- | |
483 | Goflikicept | Goflikicept | 2416984-26-2 | 抗体抑制剂- | |
484 | Golocdacimab | Golocdacimab | 2418540-63-1 | 抗体抑制剂- | |
485 | Lesabelimab | Lesabelimab | 2475402-56-1 | 抗体抑制剂- | |
486 | Letaplimab | 莱特利单抗 | Letaplimab | 2283356-07-8 | 抗体抑制剂- | |
487 | Sirtratumab | 斯妥尤单抗 | Sirtratumab | 1824663-82-2 | 抗体抑制剂- | |
488 | Siplizumab | Siplizumab | 288392-69-8 | 抗体抑制剂- | |
489 | Gosuranemab | Gosuranemab | 1788032-39-2 | 抗体抑制剂- | |
490 | Gremubamab | 格瑞巴单抗 | Gremubamab | 1800381-36-5 | 抗体抑制剂- | |
491 | Idactamab | 伊达妥单抗 | Idactamab | 2245205-37-0 | 抗体抑制剂- | |
492 | Gumokimab | Gumokimab | 2428381-52-4 | 抗体抑制剂- | |
493 | Grisnilimab | Grisnilimab | 2367001-70-3 | 抗体抑制剂- | |
494 | Ianalumab | 伊利尤单抗 | Ianalumab | 1929549-92-7 | 抗体抑制剂- | |
495 | Teropavimab | 替洛帕韦单抗 | Teropavimab | 2417213-72-8 | 抗体抑制剂- | |
496 | Emicizumab | 艾美赛珠单抗 | Emicizumab | 1610943-06-0 | 抗体抑制剂- | |
497 | Crovalimab | 可伐利单抗 | Crovalimab | 1917321-26-6 | 抗体抑制剂- | |
498 | Bezlotoxumab | 贝洛托舒单抗 | Bezlotoxumab | 1246264-45-8 | 抗体抑制剂- | |
499 | Iladatuzumab | Iladatuzumab | 1906205-76-2 | 抗体抑制剂- | |
500 | Latikafusp | Latikafusp | 2552814-07-8 | 抗体抑制剂- | |
501 | Libivirumab | 利韦单抗 | Libivirumab | 569658-79-3 | 抗体抑制剂- | |
502 | Ligufalimab | 莱法利单抗 | Ligufalimab | 2428381-55-7 | 抗体抑制剂- | |
503 | Lilotomab | 利洛托单抗 | Lilotomab | 1453362-55-4 | 抗体抑制剂- | |
504 | Livmoniplimab | 莱莫尼利单抗 | Livmoniplimab | 2412004-88-5 | 抗体抑制剂- | |
505 | Stamulumab | 司他芦单抗 | Stamulumab | 705287-60-1 | 抗体抑制剂- | |
506 | Inezetamab | Inezetamab | 2568264-76-4 | 抗体抑制剂- | |
507 | Ladiratuzumab | Ladiratuzumab | 1629760-28-6 | 抗体抑制剂- | |
508 | Laprituximab | 拉妥昔单抗 | Laprituximab | 1622327-38-1 | 抗体抑制剂- | |
509 | Larcaviximab | 拉韦昔单抗 | Larcaviximab | 1792982-56-9 | 抗体抑制剂- | |
510 | Lesofavumab | 来索伏单抗 | Lesofavumab | 1807960-57-1 | 抗体抑制剂- | |
511 | Suvizumab | 舒维组单抗 | Suvizumab | 914257-21-9 | 抗体抑制剂- | |
512 | Sotevtamab | 索泰妥单抗 | Sotevtamab | 2411526-47-9 | 抗体抑制剂- | |
513 | Sontuzumab | 松妥组单抗 | Sontuzumab | 372075-37-1 | 抗体抑制剂- | |
514 | Isecarosmab | 艾司卡索单抗 | Isecarosmab | 2254082-79-4 | 抗体抑制剂- | |
515 | Izenivetmab | Izenivetmab | 2447755-72-6 | 抗体抑制剂- | |
516 | Letolizumab | 来利珠单抗 | Letolizumab | 1450981-87-9 | 抗体抑制剂- | |
517 | Maftivimab | 玛替韦单抗 | Maftivimab | 2135632-36-7 | 抗体抑制剂- | |
518 | Itepekimab | Itepekimab | 2226742-52-3 | 抗体抑制剂- | |
519 | Socazolimab | 索卡佐利单抗 | Socazolimab | 2305043-30-3 | 抗体抑制剂- | |
520 | Iscalimab | 伊卡利单抗 | Iscalimab | 2031153-61-2 | 抗体抑制剂- | |
521 | Lutikizumab | 鲁吉珠单抗 | Lutikizumab | 1791411-57-8 | 抗体抑制剂- | |
522 | Lupartumab | 鲁帕妥单抗 | Lupartumab | 1640971-88-5 | 抗体抑制剂- | |
523 | Inolimomab | 伊诺莫单抗 | Inolimomab | 152981-31-2 | 抗体抑制剂- | |
524 | Izalontamab | Izalontamab | 2559704-24-2 | 抗体抑制剂- | |
525 | Keliximab | 凯利昔单抗 | Keliximab | 174722-30-6 | 抗体抑制剂- | |
526 | Ivonescimab | 依沃西单抗 | Ivonescimab | 2428381-53-5 | 抗体抑制剂- | |
527 | Lenvervimab | 伦韦单抗 | Lenvervimab | 2055006-79-4 | 抗体抑制剂- | |
528 | Solitomab | 索利托单抗 | Solitomab | 1005198-65-1 | 抗体抑制剂- | |
529 | Luspatercept | Luspatercept | 1373715-00-4 | 抗体抑制剂- | |
530 | Ipafricept | Ipafricept | 1391727-24-4 | 抗体抑制剂- | |
531 | Iratumumab | 伊妥木单抗 | Iratumumab | 640735-09-7 | 抗体抑制剂- | |
532 | Imaprelimab | 伊普利单抗 | Imaprelimab | 2014343-04-3 | 抗体抑制剂- | |
533 | Imsidolimab | Imsidolimab | 2102543-86-0 | 抗体抑制剂- | |
534 | Leronlimab | 乐利单抗 | Leronlimab | 674782-26-4 | 抗体抑制剂- | |
535 | Loncastuximab | 朗妥昔单抗 | Loncastuximab | 1875032-68-0 | 抗体抑制剂- | |
536 | Sotatercept | 索他西普 | Sotatercept | 1001080-50-7 | 抗体抑制剂- | |
537 | Losatuxizumab | Losatuxizumab | 1801544-27-3 | 抗体抑制剂- | |
538 | Inbakicept | Inbakicept | 2135939-52-3 | 抗体抑制剂- | |
539 | Olinvacimab | 奥伐西单抗 | Olinvacimab | 2095504-49-5 | 抗体抑制剂- | |
540 | Praluzatamab | 普罗妥单抗 | Praluzatamab | 2145109-70-0 | 抗体抑制剂- | |
541 | Manfidokimab | Manfidokimab | 2428381-56-8 | 抗体抑制剂- | |
542 | Marstacimab | 马塔西单抗 | Marstacimab | 1985638-39-8 | 抗体抑制剂- | |
543 | Melrilimab | Melrilimab | 2222865-46-3 | 抗体抑制剂- | |
544 | Murlentamab | 莫伦妥单抗 | Murlentamab | 2058047-65-5 | 抗体抑制剂- | |
545 | Osocimab | 奥索西单抗 | Osocimab | 2056878-75-0 | 抗体抑制剂- | |
546 | Pritumumab | 普林木单抗 | Pritumumab | 499212-74-7 | 抗体抑制剂- | |
547 | Ragifilimab | 拉格芙利单抗 | Ragifilimab | 2207590-51-8 | 抗体抑制剂- | |
548 | Ramatercept | Ramatercept | 1169766-01-1 | 抗体抑制剂- | |
549 | Ravagalimab | 拉瓦加利单抗 | Ravagalimab | 2050816-56-1 | 抗体抑制剂- | |
550 | Depemokimab | 德莫奇单抗 | Depemokimab | 2243274-14-6 | 抗体抑制剂- | |
551 | Dilpacimab | 迪帕西单抗 | Dilpacimab | 1791420-09-1 | 抗体抑制剂- | |
552 | Domagrozumab | 多玛洛珠单抗 | Domagrozumab | 1629605-31-7 | 抗体抑制剂- | |
553 | Domvanalimab | 多瓦那利单抗 | Domvanalimab | 2368219-35-4 | 抗体抑制剂- | |
554 | Cosfroviximab | 考韦昔单抗 | Cosfroviximab | 1792982-57-0 | 抗体抑制剂- | |
555 | Cosibelimab | 柯希利单抗 | Cosibelimab | 2216751-26-5 | 抗体抑制剂- | |
556 | Crenezumab | 克瑞组单抗 | Crenezumab | 1095207-05-8 | 抗体抑制剂- | |
557 | Nirsevimab | 尼塞韦单抗 | Nirsevimab | 1989556-22-0 | 抗体抑制剂- | |
558 | Olaratumab | 奥拉单抗 | Olaratumab | 1024603-93-7 | 抗体抑制剂- | |
559 | Mapatumumab | 马帕木单抗 | Mapatumumab | 658052-09-6 | 抗体抑制剂- | |
560 | Zansecimab | Zansecimab | 2415205-37-5 | 抗体抑制剂- | |
561 | Zampilimab | 佐比利单抗 | Zampilimab | 2098280-42-1 | 抗体抑制剂- | |
562 | Xeligekimab | 赛立奇单抗 | Xeligekimab | 2382921-73-3 | 抗体抑制剂- | |
563 | Suptavumab | 舒他伏单抗 | Suptavumab | 1629615-23-1 | 抗体抑制剂- | |
564 | Minretumomab | 明瑞莫单抗 | Minretumomab | 195189-17-4 | 抗体抑制剂- | |
565 | Mirzotamab | 米佐妥单抗 | Mirzotamab | 2229859-11-2 | 抗体抑制剂- | |
566 | Nofazinlimab | 诺法利单抗 | Nofazinlimab | 2377845-98-0 | 抗体抑制剂- | |
567 | Obexelimab | 奥贝利单抗 | Obexelimab | 1690307-05-1 | 抗体抑制剂- | |
568 | Omodenbamab | Omodenbamab | 2241724-48-9 | 抗体抑制剂- | |
569 | Plozalizumab | 洛扎利珠单抗 | Plozalizumab | 1610761-46-0 | 抗体抑制剂- | |
570 | Orilanolimab | 奥诺利单抗 | Orilanolimab | 2066544-85-0 | 抗体抑制剂- | |
571 | Orticumab | 奥替苏单抗 | Orticumab | 1314241-10-5 | 抗体抑制剂- | |
572 | Otilimab | 奥替利单抗 | Otilimab | 1638332-55-4 | 抗体抑制剂- | |
573 | Pasotuxizumab | 帕妥昔珠单抗 | Pasotuxizumab | 1442657-12-6 | 抗体抑制剂- | |
574 | Rafivirumab | 雷韦单抗 | Rafivirumab | 944548-37-2 | 抗体抑制剂- | |
575 | Datopotamab | 德达博妥单抗 | Datopotamab | 2267989-53-5 | 抗体抑制剂- | |
576 | Rovelizumab | 罗维珠单抗 | Rovelizumab | 339086-79-2 | 抗体抑制剂- | |
577 | Eftilagimod alfa | Eftilagimod alfa | 1800476-36-1 | 抗体抑制剂- | |
578 | Eftozanermin alfa | Eftozanermin alfa | 1820660-69-2 | 抗体抑制剂- | |
579 | Elgemtumab | 依更妥单抗 | Elgemtumab | 1512559-37-3 | 抗体抑制剂- | |
580 | Elipovimab | 依帕韦单抗 | Elipovimab | 2101210-43-7 | 抗体抑制剂- | |
581 | Revdofilimab | Revdofilimab | 2230138-89-1 | 抗体抑制剂- | |
582 | Rimteravimab | 瑞特韦单抗 | Rimteravimab | 2540797-21-3 | 抗体抑制剂- | |
583 | Diridavumab | 地利伏单抗 | Diridavumab | 1393659-46-5 | 抗体抑制剂- | |
584 | Cantuzumab | 坎妥珠单抗 | Cantuzumab | 1204740-23-7 | 抗体抑制剂- | |
585 | Clivatuzumab | 克利妥珠单抗 | Clivatuzumab | 1622075-09-5 | 抗体抑制剂- | |
586 | Cudarolimab | Cudarolimab | 2244739-29-3 | 抗体抑制剂- | |
587 | Pavurutamab | 帕武鲁他单抗 | Pavurutamab | 2250292-39-6 | 抗体抑制剂- | |
588 | Recaticimab | 瑞卡西单抗 | Recaticimab | 2361290-85-7 | 抗体抑制剂- | |
589 | Cobolimab | 考伯利单抗 | Cobolimab | 2022215-65-0 | 抗体抑制剂- | |
590 | Ontorpacept | Ontorpacept | 2131089-46-6 | 抗体抑制剂- | |
591 | Navivumab | 那韦伏单抗 | Navivumab | 1443004-16-7 | 抗体抑制剂- | |
592 | Netakimab | 尼塔奇单抗 | Netakimab | 1796570-08-5 | 抗体抑制剂- | |
593 | Opicinumab | 奥匹努单抗 | Opicinumab | 1422268-07-2 | 抗体抑制剂- | |
594 | Mezagitamab | 迈泽妥单抗 | Mezagitamab | 2227490-52-8 | 抗体抑制剂- | |
595 | Nurulimab | 诺瑞利单抗 | Nurulimab | 2168561-20-2 | 抗体抑制剂- | |
596 | Odesivimab | 奥西韦单抗 | Odesivimab | 2135632-30-1 | 抗体抑制剂- | |
597 | Ociperlimab | 欧司珀利单抗 | Ociperlimab | 2342597-93-5 | 抗体抑制剂- | |
598 | Mipasetamab | 米帕妥单抗 | Mipasetamab | 2361055-48-1 | 抗体抑制剂- | |
599 | Pozelimab | 帕泽利单抗 | Pozelimab | 2096328-94-6 | 抗体抑制剂- | |
600 | Ontuxizumab | 昂妥昔珠单抗 | Ontuxizumab | 946415-62-9 | 抗体抑制剂- | |
601 | Plamotamab | 帕拉莫妥单抗 | Plamotamab | 2138442-31-4 | 抗体抑制剂- | |
602 | Mitazalimab | 米佐利单抗 | Mitazalimab | 2055640-86-1 | 抗体抑制剂- | |
603 | Milatuzumab | 米拉组单抗 | Milatuzumab | 899796-83-9 | 抗体抑制剂- | |
604 | Anti-Human IL-17A | Secukinumab (Anti-Human IL-17A) | 1229022-83-6 | 抗体抑制剂- | |
605 | Brolucizumab | 布洛赛珠单抗 | Brolucizumab | 1531589-13-5 | 抗体抑制剂- | |
606 | Epcoritamab | 艾可瑞妥单抗 | Epcoritamab | 2134641-34-0 | 抗体抑制剂- | |
607 | Faricimab | 法瑞西单抗 | Faricimab | 1607793-29-2 | 抗体抑制剂- | |
608 | Bintrafusp alfa | Bintrafusp alfa | 1918149-01-5 | 抗体抑制剂- | |
609 | Abatacept | 阿巴西普 | Abatacept | 332348-12-6 | 抗体抑制剂- | |
610 | Natalizumab | 那他珠单抗 | Natalizumab | 189261-10-7 | 抗体抑制剂- | |
611 | Benralizumab | 贝那利珠单抗 | Benralizumab | 1044511-01-4 | 抗体抑制剂- | |
612 | Dupilumab | 杜匹鲁单抗 | Dupilumab | 1190264-60-8 | 抗体抑制剂- | |
613 | Reslizumab | 瑞利珠单抗 | Reslizumab | 241473-69-8 | 抗体抑制剂- | |
614 | Raleukin | 阿那白滞素 | Raleukin | 143090-92-0 | 抗体抑制剂- | |
615 | Infliximab | 英夫利昔单抗 | Infliximab | 170277-31-3 | 抗体抑制剂- | |
616 | Daratumumab | 达雷木单抗 | Daratumumab | 945721-28-8 | 抗体抑制剂- | |
617 | Ixekizumab | 伊西贝单抗 | Ixekizumab | 1143503-69-8 | 抗体抑制剂- | |
618 | Secukinumab | 司库奇尤单抗 | Secukinumab | 1229022-83-6 | 抗体抑制剂- | |
619 | Camrelizumab | 卡瑞利珠单抗 | Camrelizumab | 1798286-48-2 | 抗体抑制剂- | |
620 | Omalizumab | 奥马珠单抗 | Omalizumab | 242138-07-4 | 抗体抑制剂- | |
621 | Nimotuzumab | 尼妥珠单抗 | Nimotuzumab | 780758-10-3 | 抗体抑制剂- | |
622 | Isatuximab | 艾萨妥昔单抗 | Isatuximab | 1461640-62-9 | 抗体抑制剂- | |
623 | Bevacizumab | 贝伐单抗 (PBS) | Bevacizumab (PBS) | 216974-75-3 | 抗体抑制剂- | |
624 | Pertuzumab | 帕妥株单抗 (anti-HER2) | Pertuzumab (anti-HER2) | 380610-27-5 | 抗体抑制剂- | |
625 | Rozanolixizumab | 洛利昔珠单抗 | Rozanolixizumab | 1584645-37-3 | 抗体抑制剂- | |
626 | Rovalpituzumab | 洛伐妥珠单抗 | Rovalpituzumab | 1613313-01-1 | 抗体抑制剂- | |
627 | Ofatumumab | 奥法木单抗 | Ofatumumab | 679818-59-8 | 抗体抑制剂- | |
628 | Sacituzumab | 戈沙妥珠单抗 | Sacituzumab | 1796566-95-4 | 抗体抑制剂- | |
629 | Girentuximab | 吉妥昔单抗 | Girentuximab | 916138-87-9 | 抗体抑制剂- | |
630 | Sabatolimab | 沙巴托利单抗 | Sabatolimab | 2252262-24-9 | 抗体抑制剂- | |
631 | Evolocumab | 依洛尤单抗 | Evolocumab | 1256937-27-5 | 抗体抑制剂- | |
632 | Alirocumab | 阿利西尤单抗 | Alirocumab | 1245916-14-6 | 抗体抑制剂- | |
633 | Aducanumab | 阿杜那单抗 | Aducanumab | 1384260-65-4 | 抗体抑制剂- | |
634 | Amatuximab | 阿麦妥单抗 | Amatuximab | 931402-35-6 | 抗体抑制剂- | |
635 | Etokimab | 艾托奇单抗 | Etokimab | 2022981-44-6 | 抗体抑制剂- | |
636 | Fresolimumab | 非苏木单抗 | Fresolimumab | 948564-73-6 | 抗体抑制剂- | |
637 | Fremanezumab | 瑞玛奈珠单抗 | Fremanezumab | 1655501-53-3 | 抗体抑制剂- | |
638 | Atibuclimab | 阿替布利单抗 | Atibuclimab | 2417175-94-9 | 抗体抑制剂- | |
639 | Alemtuzumab | 阿伦单抗 | Alemtuzumab | 216503-57-0 | 抗体抑制剂- | |
640 | Aprutumab | 阿普卢妥单抗 | Aprutumab | 1634620-63-5 | 抗体抑制剂- | |
641 | Bemarituzumab | 贝玛妥珠单抗 | Bemarituzumab | 1952272-74-0 | 抗体抑制剂- | |
642 | Belantamab | 贝兰妥单抗 | Belantamab | 2061894-48-0 | 抗体抑制剂- | |
643 | Belimumab | 贝利尤单抗 | Belimumab | 356547-88-1 | 抗体抑制剂- | |
644 | Selicrelumab | 塞鲁单抗 | Selicrelumab | 1622140-49-1 | 抗体抑制剂- | |
645 | Eculizumab | 依库珠单抗 | Eculizumab | 219685-50-4 | 抗体抑制剂- | |
646 | Lemzoparlimab | 来佐利单抗 | Lemzoparlimab | 2377483-71-9 | 抗体抑制剂- | |
647 | Magrolimab | 莫洛利单抗 | Magrolimab | 2169232-81-7 | 抗体抑制剂- | |
648 | Oleclumab | 奥来鲁单抗 | Oleclumab | 1803176-05-7 | 抗体抑制剂- | |
649 | Onvatilimab | 奥瓦利单抗 | Onvatilimab | 1969313-51-6 | 抗体抑制剂- | |
650 | Panitumumab | 帕尼单抗 | Panitumumab | 339177-26-3 | 抗体抑制剂- | |
651 | Varlilumab | 伐立鲁单抗 | Varlilumab | 1393344-72-3 | 抗体抑制剂- | |
652 | Guselkumab | 古塞库单抗 | Guselkumab | 1350289-85-8 | 抗体抑制剂- | |
653 | Batoclimab | 巴托利单抗 | Batoclimab | 2187430-05-1 | 抗体抑制剂- | |
654 | Cibisatamab | 赛必妥单抗 | Cibisatamab | 1855925-27-7 | 抗体抑制剂- | |
655 | Galcanezumab | 加卡奈珠单抗 | Galcanezumab | 1578199-75-3 | 抗体抑制剂- | |
656 | Dacetuzumab | 达西组单抗 | Dacetuzumab | 880486-59-9 | 抗体抑制剂- | |
657 | Enfortumab | 恩诺单抗 | Enfortumab | 1448664-46-7 | 抗体抑制剂- | |
658 | Eptinezumab | 艾普奈珠单抗 | Eptinezumab | 1644539-04-7 | 抗体抑制剂- | |
659 | Ibalizumab | 艾巴利珠单抗 | Ibalizumab | 680188-33-4 | 抗体抑制剂- | |
660 | Erenumab | 依瑞奈尤单抗 | Erenumab | 1582205-90-0 | 抗体抑制剂- | |
661 | Denosumab | 地舒单抗 | Denosumab | 615258-40-7 | 抗体抑制剂- | |
662 | Cusatuzumab | 古妥珠单抗 | Cusatuzumab | 1864871-20-4 | 抗体抑制剂- | |
663 | Blinatumomab | 贝林妥欧单抗 | Blinatumomab | 853426-35-4 | 抗体抑制剂- | |
664 | Gantenerumab | 更汀芦单抗 | Gantenerumab | 1043556-46-2 | 抗体抑制剂- | |
665 | Daclizumab | 达昔单抗 | Daclizumab | 152923-56-3 | 抗体抑制剂- | |
666 | Margetuximab | 玛格妥昔单抗 | Margetuximab | 1350624-75-7 | 抗体抑制剂- | |
667 | Elotuzumab | 埃罗妥珠单抗 | Elotuzumab | 915296-00-3 | 抗体抑制剂- | |
668 | Vedolizumab (anti-α4β7-integrin) | Vedolizumab (anti-α4β7-integrin) | 943609-66-3 | 抗体抑制剂- | |
669 | Rituximab (anti-CD20) | Rituximab (anti-CD20) | 174722-31-7 | 抗体抑制剂- | |
670 | Tralokinumab | 曲罗芦单抗 | Tralokinumab | 1044515-88-9 | 抗体抑制剂- | |
671 | Mavrilimumab | 玛弗利木单抗 | Mavrilimumab | 1085337-57-0 | 抗体抑制剂- | |
672 | Monalizumab | 莫那利珠单抗 | Monalizumab | 1228763-95-8 | 抗体抑制剂- | |
673 | Nesvacumab | 奈伐苏单抗 | Nesvacumab | 1296818-77-3 | 抗体抑制剂- | |
674 | Simtuzumab | 辛妥珠单抗 | Simtuzumab | 1318075-13-6 | 抗体抑制剂- | |
675 | Naptumomab | 那普妥莫单抗 | Naptumomab | 1412892-09-1 | 抗体抑制剂- | |
676 | Odronextamab | 奥尼妥单抗 | Odronextamab | 1801338-64-6 | 抗体抑制剂- | |
677 | Tislelizumab | 替雷利珠单抗 | Tislelizumab | 1858168-59-8 | 抗体抑制剂- | |
678 | Mosunetuzumab | 莫妥珠单抗 | Mosunetuzumab | 1905409-39-3 | 抗体抑制剂- | |
679 | Spartalizumab | 斯巴达珠单抗 | Spartalizumab | 1935694-88-4 | 抗体抑制剂- | |
680 | Sutimlimab | 苏替莫单抗 | Sutimlimab | 2049079-64-1 | 抗体抑制剂- | |
681 | Sintilimab | 信迪利单抗 | Sintilimab | 2072873-06-2 | 抗体抑制剂- | |
682 | Nipocalimab | 尼卡利单抗 | Nipocalimab | 2211985-36-1 | 抗体抑制剂- | |
683 | Tinurilimab | 替奴瑞利单抗 | Tinurilimab | 2226224-30-0 | 抗体抑制剂- | |
684 | Polatuzumab | 维泊妥珠单抗 | Polatuzumab | 2279068-37-8 | 抗体抑制剂- | |
685 | Sotigalimab | Sotigalimab | 2305607-45-6 | 抗体抑制剂- | |
686 | Tusamitamab | 特赛妥单抗 | Tusamitamab | 2349294-95-5 | 抗体抑制剂- | |
687 | Matuzumab | 马妥珠单抗 | Matuzumab | 339186-68-4 | 抗体抑制剂- | |
688 | Theralizumab | 西拉利珠单抗 | Theralizumab | 906068-56-2 | 抗体抑制剂- | |
689 | Urelumab | 乌瑞芦单抗 | Urelumab | 934823-49-1 | 抗体抑制剂- | |
690 | Lebrikizumab | 来瑞组单抗 | Lebrikizumab | 953400-68-5 | 抗体抑制剂- | |
691 | Utomilumab | 乌托鲁单抗 | Utomilumab | 1417318-27-4 | 抗体抑制剂- | |
692 | Palivizumab | 帕利珠单抗 | Palivizumab | 188039-54-5 | 抗体抑制剂- | |
693 | Tiragolumab | 替瑞利尤单抗 | Tiragolumab | 1918185-84-8 | 抗体抑制剂- | |
694 | Toripalimab | 特瑞普利单抗 | Toripalimab | 1924598-82-2 | 抗体抑制剂- | |
695 | Mepolizumab | 美泊利单抗 | Mepolizumab | 196078-29-2 | 抗体抑制剂- | |
696 | Clazakizumab | 克拉扎珠单抗 | Clazakizumab | 1236278-28-6 | 抗体抑制剂- | |
697 | Codrituzumab | 考曲妥珠单抗 | Codrituzumab | 1365267-33-9 | 抗体抑制剂- | |
698 | Igovomab | 伊戈伏单抗 | Igovomab | 171656-50-1 | 抗体抑制剂- | |
699 | Certolizumab pegol | 培塞利珠单抗 | Certolizumab pegol | 428863-50-7 | 抗体抑制剂- | |
700 | Penpulimab | 派安普利单抗 | Penpulimab | 2350298-92-7 | 抗体抑制剂- | |
701 | Zimberelimab | 赛帕利单抗 | Zimberelimab | 2259860-24-5 | 抗体抑制剂- | |
702 | Lanadelumab | 拉那鲁单抗 | Lanadelumab | 1426055-14-2 | 抗体抑制剂- | |
703 | Satralizumab | 萨特利珠单抗 | Satralizumab | 1535963-91-7 | 抗体抑制剂- | |
704 | Inebilizumab | 伊奈利珠单抗 | Inebilizumab | 1299440-37-1 | 抗体抑制剂- | |
705 | Sugemalimab | 舒格利单抗 | Sugemalimab | 2256084-03-2 | 抗体抑制剂- | |
706 | Envafolimab | 恩沃利单抗 | Envafolimab | 2102192-68-5 | 抗体抑制剂- | |
707 | Cadonilimab | 卡度尼利单抗 | Cadonilimab | 2394841-59-7 | 抗体抑制剂- | |
708 | Tafasitamab | 坦昔妥单抗 | Tafasitamab | 1422527-84-1 | 抗体抑制剂- | |
709 | Golimumab | 戈利木单抗 | Golimumab | 476181-74-5 | 抗体抑制剂- | |
710 | Epoetin beta | Epoetin beta | 122312-54-3 | 抗体抑制剂- | |
711 | Abciximab | 阿昔单抗 | Abciximab | 143653-53-6 | 抗体抑制剂- | |
712 | Tremelimumab | 曲美木单抗 | Tremelimumab | 745013-59-6 | 抗体抑制剂- | |
713 | Alirocumab | 阿利西尤单抗 (anti-PCSK9) | Alirocumab (anti-PCSK9) | 1245916-14-6 | 抗体抑制剂- | |
714 | Dafsolimab | 达索利单抗 | Dafsolimab | 2367001-71-4 | 抗体抑制剂- | |
715 | Dectrekumab | 德屈库单抗 | Dectrekumab | 1528523-94-5 | 抗体抑制剂- | |
716 | Plutavimab | Plutavimab | 2529854-88-2 | 抗体抑制剂- | |
717 | Acrixolimab | Acrixolimab | 2506324-29-2 | 抗体抑制剂- | |
718 | Mecbotamab | Mecbotamab | 2460400-28-4 | 抗体抑制剂- | |
719 | Efungumab | 依芬古单抗 | Efungumab | 762260-74-2 | 抗体抑制剂- | |
720 | Sulesomab | 硫索单抗 | Sulesomab | 167747-19-5 | 抗体抑制剂- | |
721 | Davoceticept | Davoceticept | 2307144-64-3 | 抗体抑制剂- | |
722 | Ebronucimab | 伊努西单抗 | Ebronucimab | 2304800-90-4 | 抗体抑制剂- | |
723 | Efaprinermin alfa | Efaprinermin alfa | 2102200-64-4 | 抗体抑制剂- | |
724 | Roledumab | 罗来度单抗 | Roledumab | 1174008-79-7 | 抗体抑制剂- | |
725 | Romilkimab | 若奇单抗 | Romilkimab | 1399584-78-1 | 抗体抑制剂- | |
726 | Sasanlimab | 萨善利单抗 | Sasanlimab | 2206792-50-7 | 抗体抑制剂- | |
727 | Pimurutamab | 匹姆瑞妥单抗 | Pimurutamab | 2251771-76-1 | 抗体抑制剂- | |
728 | Rozibafusp alfa | Rozibafusp alfa | 2143449-47-0 | 抗体抑制剂- | |
729 | Setoxaximab | 瑟托萨昔单抗 | Setoxaximab | 1351470-17-1 | 抗体抑制剂- | |
730 | Crexavibart | Crexavibart | 2599039-61-7 | 抗体抑制剂- | |
731 | Devextinetug | Devextinetug | 2609642-90-0 | 抗体抑制剂- | |
732 | Ralzapastotug | Ralzapastotug | 2581724-89-0 | 抗体抑制剂- | |
733 | Tuparstobart | Tuparstobart | 2649466-03-3 | 抗体抑制剂- | |
734 | Varokibart | Varokibart | 2643349-04-4 | 抗体抑制剂- | |
735 | Freneslerbart | Freneslerbart | 2453195-94-1 | 抗体抑制剂- | |
736 | Bremzalerbart | Bremzalerbart | 2456307-07-4 | 抗体抑制剂- | |
737 | Pritoxaximab | 瑞托萨昔单抗 | Pritoxaximab | 1351470-16-0 | 抗体抑制剂- | |
738 | Narlumosbart | 纳鲁索拜单抗 | Narlumosbart | 2646587-68-8 | 抗体抑制剂- | |
739 | Epacmarstobart | Epacmarstobart | 2518200-89-8 | 抗体抑制剂- | |
740 | Mevonlerbart | Mevonlerbart | 2453195-99-6 | 抗体抑制剂- | |
741 | Lorukafusp alfa | Lorukafusp alfa | 2131168-99-3 | 抗体抑制剂- | |
742 | Pidilizumab | 匹地利珠单抗 | Pidilizumab | 1036730-42-3 | 抗体抑制剂- | |
743 | Denecimig | Denecimig | 2488745-86-2 | 抗体抑制剂- | |
744 | Atisnolerbart | Atisnolerbart | 2456308-79-3 | 抗体抑制剂- | |
745 | Lipustobart | 利普苏拜单抗 | Lipustobart | 2639481-06-2 | 抗体抑制剂- | |
746 | Umesolerbart | Umesolerbart | 2456307-11-0 | 抗体抑制剂- | |
747 | Danburstotug | 达布苏塔单抗 | Danburstotug | 2307144-65-4 | 抗体抑制剂- | |
748 | Prafnosbart | 帕拉索拜单抗 | Prafnosbart | 2566473-71-8 | 抗体抑制剂- | |
749 | Calpurbatug | Calpurbatug | 2635404-72-5 | 抗体抑制剂- | |
750 | Eglatoprutug | Eglatoprutug | 2518200-21-8 | 抗体抑制剂- | |
751 | Sofituzumab vedotin (solution) | Sofituzumab vedotin (solution) | 1418200-58-4 | 抗体抑制剂- | |
752 | Erlizumab | 厄利珠单抗 | Erlizumab | 211323-03-4 | 抗体抑制剂- | |
753 | Emfizatamab | Emfizatamab | 2559704-23-1 | 抗体抑制剂- | |
754 | Emirodatamab | Emirodatamab | 2449199-61-3 | 抗体抑制剂- | |
755 | Emerfetamab | 艾鲁妥单抗 | Emerfetamab | 2250261-27-7 | 抗体抑制剂- | |
756 | Etevritamab | 艾替瑞妥单抗 | Etevritamab | 2329692-74-0 | 抗体抑制剂- | |
757 | Adalimumab (Powder) | Adalimumab (Powder) | 331731-18-1 | 抗体抑制剂- | |
758 | Naratuximab emtansine | Naratuximab emtansine | 1607824-64-5 | 抗体抑制剂- | |
759 | Indatuximab ravtansine | Indatuximab ravtansine | 1238517-16-2 | 抗体抑制剂- | |
760 | Rolinsatamab talirine | Rolinsatamab talirine | 2095467-44-8 | 抗体抑制剂- | |
761 | Masavibart | Masavibart | 2640223-84-1 | 抗体抑制剂- | |
762 | Nepuvibart | Nepuvibart | 2640224-48-0 | 抗体抑制剂- | |
763 | Narnatumab | 那呐妥单抗 | Narnatumab | 1188275-92-4 | 抗体抑制剂- | |
764 | Tuvirumab | 妥韦单抗 | Tuvirumab | 138660-97-6 | 抗体抑制剂- | |
765 | Taplitumomab paptox | Taplitumomab paptox | 235428-87-2 | 抗体抑制剂- | |
766 | Efdamrofusp alfa | Efdamrofusp alfa | 2375661-82-6 | 抗体抑制剂- | |
767 | Efgivanermin alfa | Efgivanermin alfa | 1807864-13-6 | 抗体抑制剂- | |
768 | Gimsilumab | 瑾司鲁单抗 | Gimsilumab | 1648796-29-5 | 抗体抑制剂- | |
769 | Lerdelimumab | 乐德木单抗 | Lerdelimumab | 285985-06-0 | 抗体抑制剂- | |
770 | Levilimab | 乐维利单抗 | Levilimab | 2035008-70-7 | 抗体抑制剂- | |
771 | Pexelizumab | 培克珠单抗 | Pexelizumab | 219685-93-5 | 抗体抑制剂- | |
772 | Sevirumab | 司韦单抗 | Sevirumab | 138660-96-5 | 抗体抑制剂- | |
773 | Zeluvalimab | Zeluvalimab | 2315361-37-4 | 抗体抑制剂- | |
774 | Lomtegovimab | 洛替韦单抗 | Lomtegovimab | 2550869-33-3 | 抗体抑制剂- | |
775 | Lodapolimab | 洛达利单抗 | Lodapolimab | 2118349-31-6 | 抗体抑制剂- | |
776 | Istiratumab | 艾司妥单抗 | Istiratumab | 1509928-04-4 | 抗体抑制剂- | |
777 | Lenercept | Lenercept | 156679-34-4 | 抗体抑制剂- | |
778 | Lepunafusp alfa | Lepunafusp alfa | 2396411-71-3 | 抗体抑制剂- | |
779 | Izuralimab | Izuralimab | 2329669-80-7 | 抗体抑制剂- | |
780 | Opinercept | Opinercept | 2055118-96-0 | 抗体抑制剂- | |
781 | Onercept | Onercept | 199685-57-9 | 抗体抑制剂- | |
782 | Clervonafusp alfa | Clervonafusp alfa | 2145123-44-8 | 抗体抑制剂- | |
783 | Pegacaristim | Pegacaristim | 187139-68-0 | 抗体抑制剂- | |
784 | Ranevetmab | Ranevetmab | 1632282-27-9 | 抗体抑制剂- | |
785 | Relfovetmab | 瑞弗维单抗 | Relfovetmab | 2171034-70-9 | 抗体抑制剂- | |
786 | Docaravimab | 多可瑞韦单抗 | Docaravimab | 2247196-23-0 | 抗体抑制剂- | |
787 | Crefmirlimab | Crefmirlimab | 2611099-93-3 | 抗体抑制剂- | |
788 | Maslimomab | 马司莫单抗 | Maslimomab | 127757-92-0 | 抗体抑制剂- | |
789 | Miptenalimab | Miptenalimab | 2249882-55-9 | 抗体抑制剂- | |
790 | Onfekafusp alfa | Onfekafusp alfa | 1957239-88-1 | 抗体抑制剂- | |
791 | Ormutivimab | 奥木替韦单抗 | Ormutivimab | 2449086-91-1 | 抗体抑制剂- | |
792 | Ralpancizumab | 雷泮赛珠单抗 | Ralpancizumab | 1407495-04-8 | 抗体抑制剂- | |
793 | Rivabazumab | 利伐巴珠单抗 | Rivabazumab | 1627519-84-9 | 抗体抑制剂- | |
794 | Nerelimomab | 奈瑞莫单抗 | Nerelimomab | 162774-06-3 | 抗体抑制剂- | |
795 | Placulumab | 普拉鲁单抗 | Placulumab | 945781-29-3 | 抗体抑制剂- | |
796 | Ongericimab | 昂戈瑞西单抗 | Ongericimab | 2145096-91-7 | 抗体抑制剂- | |
797 | Opucolimab | 欧可利单抗 | Opucolimab | 2251771-79-4 | 抗体抑制剂- | |
798 | Mitumomab | 米妥莫单抗 | Mitumomab | 216503-58-1 | 抗体抑制剂- | |
799 | Plonmarlimab | 普那利单抗 | Plonmarlimab | 2377482-36-3 | 抗体抑制剂- | |
800 | Anetumab ravtansine | Anetumab ravtansine | 1375258-01-7 | 抗体抑制剂- | |
801 | Indusatumab vedotin | Indusatumab vedotin | 1514889-12-3 | 抗体抑制剂- | |
802 | Laprituximab emtansine | Laprituximab emtansine | 1622327-37-0 | 抗体抑制剂- | |
803 | Sirtratumab vedotin | 纬斯妥尤单抗 | Sirtratumab vedotin | 1824663-83-3 | 抗体抑制剂- | |
804 | Lifastuzumab vedotin | Lifastuzumab vedotin | 1401812-88-1 | 抗体抑制剂- | |
805 | Vorsetuzumab mafodotin | Vorsetuzumab mafodotin | 1165741-01-4 | 抗体抑制剂- | |